Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Sundrug Co ( (JP:9989) ) has issued an update.
Sundrug Co., Ltd. has completed the payment for the disposal of 15,600 treasury shares as restricted stock compensation, a decision made during the Board of Directors’ meeting on June 20, 2025. This move is aimed at aligning the interests of its directors and executive officers with the company’s performance, potentially impacting its corporate governance and stakeholder relations.
The most recent analyst rating on (JP:9989) stock is a Buy with a Yen5400.00 price target. To see the full list of analyst forecasts on Sundrug Co stock, see the JP:9989 Stock Forecast page.
More about Sundrug Co
Sundrug Co., Ltd. operates in the retail industry, primarily focusing on pharmaceuticals and health-related products. It is listed on the Tokyo Stock Exchange, Prime Market, and is led by CEO Hiroshi Sadakata.
Average Trading Volume: 342,788
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen537.6B
For an in-depth examination of 9989 stock, go to TipRanks’ Overview page.